Trials of Oxford’s Covid-19 Vaccine Proves Perfectly Safe With Immune Reaction Lasting 2 Months or Longer: Launching In December
The biological war against Covid-19 is in full swing and though the current scenario still looks like the world may face a bleak winter, hopes are on the rise in the form of vaccines being developed around the world that seem to be showing promising results in human trials. One particular vaccine developed by scientists at Oxford University has shown that it is completely safe and even gives immunity for up to two months. Scientists are confident that the vaccine could be ready by December and human trials have found participants have also developed killer T cells and antibodies against the virus.
1New vaccine developed by Oxford University can promote a strong immune response
Oxford University’s new vaccine called AZD1222 developed for pharmaceutical giant AstraZeneca has tested safe in humans and provoked immune response that lasted around 56 days or more as per the results published in the Lancet. The positive results were observed in 91% of volunteers however, it is yet to be licensed for human use because of no conclusive proof as yet that it will work. As of now, scientists explain, it only shows promise. Lead scientists are optimistic saying that the vaccine could even be ready by December if further trials work according to plan.

Image Source: dailymail.co.uk
O
2One of the leading vaccines among those being developed in different countries
The vaccine will be tested against those high-risk patients who will be receiving their first jabs in December. Prime Minister Boris Johnson has reacted positively to the news by even giving an advance order of 100 million doses. The British vaccine is among the front runner in the race for vaccines being developed in different countries. Thus far vaccines in China, Germany, France and the US are showing exceptional results.

Image Source: france24.com
3The vaccine shows no serious side effects
What is one big advantage of the vaccine developed at Oxford is the lack of major or serious side effects. In fact, as hoped, it is stimulating the immune response to produce antibodies and trigger killer T cells to work. Among side effects in volunteers were the usual headache, tiredness and arm pain which aren’t of much consequence and usually the common side effects associated with most vaccines. After all, it is the lifesaving benefit that counts more than a headache.

Image Source: pinimg.com